PL353349A1 - Sposób wydzielania i oczyszczania alergenów pyłków traw - Google Patents

Sposób wydzielania i oczyszczania alergenów pyłków traw

Info

Publication number
PL353349A1
PL353349A1 PL00353349A PL35334900A PL353349A1 PL 353349 A1 PL353349 A1 PL 353349A1 PL 00353349 A PL00353349 A PL 00353349A PL 35334900 A PL35334900 A PL 35334900A PL 353349 A1 PL353349 A1 PL 353349A1
Authority
PL
Poland
Prior art keywords
grass pollen
isolating
purifying
pollen allergens
pollen
Prior art date
Application number
PL00353349A
Other languages
English (en)
Other versions
PL205323B1 (pl
Inventor
Roland Suck
Oliver Cromwell
Helmut Fiebig
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7919344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL353349(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL353349A1 publication Critical patent/PL353349A1/pl
Publication of PL205323B1 publication Critical patent/PL205323B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5097—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353349A 1999-08-24 2000-08-18 Sposób wydzielania i oczyszczania alergenów pyłków traw grup 1, 2, 3, 10 i 13 oraz sposób otrzymywania alergenów pyłków traw grupy 13 PL205323B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19939982A DE19939982A1 (de) 1999-08-24 1999-08-24 Verfahren zur Isolierung und Aufreinigung von Gräserpollenallergenen
PCT/EP2000/008059 WO2001013946A2 (de) 1999-08-24 2000-08-18 Verfahren zur isolierung und aufreinigung von gräserpollenallergenen

Publications (2)

Publication Number Publication Date
PL353349A1 true PL353349A1 (pl) 2003-11-17
PL205323B1 PL205323B1 (pl) 2010-04-30

Family

ID=7919344

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353349A PL205323B1 (pl) 1999-08-24 2000-08-18 Sposób wydzielania i oczyszczania alergenów pyłków traw grup 1, 2, 3, 10 i 13 oraz sposób otrzymywania alergenów pyłków traw grupy 13

Country Status (20)

Country Link
US (3) US7326769B1 (pl)
EP (1) EP1206488B2 (pl)
JP (1) JP4942892B2 (pl)
KR (1) KR20020019965A (pl)
CN (1) CN1205222C (pl)
AT (1) ATE297408T1 (pl)
AU (1) AU776154B2 (pl)
CA (1) CA2381340C (pl)
CZ (1) CZ2002500A3 (pl)
DE (2) DE19939982A1 (pl)
ES (1) ES2241646T5 (pl)
HU (1) HUP0203744A2 (pl)
MX (1) MXPA02001949A (pl)
NO (1) NO20020884D0 (pl)
PL (1) PL205323B1 (pl)
PT (1) PT1206488E (pl)
RU (1) RU2242248C2 (pl)
SK (1) SK2202002A3 (pl)
WO (1) WO2001013946A2 (pl)
ZA (1) ZA200202288B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102096B4 (de) * 2001-01-18 2007-08-09 BLüCHER GMBH Geruchsadsorbierende Berufsbekleidung
SE0200946D0 (sv) * 2002-03-27 2002-03-27 Pharmacia Diagnostics Ab Novel Allergen
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
JP5279238B2 (ja) * 2006-11-16 2013-09-04 森川健康堂株式会社 血圧降下作用を有する花粉の製造方法
CN101678318B (zh) * 2007-05-25 2013-09-25 默克专利股份公司 用于阳离子交换色谱法的接枝共聚物
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05509230A (ja) * 1990-08-17 1993-12-22 ザ・ユニバーシテイ・オブ・メルボルン ライグラスの花粉のアレルゲン
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
AT401937B (de) * 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
DE19918682A1 (de) * 1999-04-23 2000-10-26 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung eines Graminaen-Allergens

Also Published As

Publication number Publication date
US7326769B1 (en) 2008-02-05
NO20020884L (no) 2002-02-22
EP1206488B2 (de) 2015-10-14
US20080118991A1 (en) 2008-05-22
PL205323B1 (pl) 2010-04-30
CA2381340A1 (en) 2001-03-01
WO2001013946A3 (de) 2001-06-07
DE50010525D1 (de) 2005-07-14
ZA200202288B (en) 2003-06-20
EP1206488A2 (de) 2002-05-22
CA2381340C (en) 2015-07-14
ES2241646T5 (es) 2016-01-22
JP2003507432A (ja) 2003-02-25
WO2001013946A2 (de) 2001-03-01
HUP0203744A2 (hu) 2003-04-28
ES2241646T3 (es) 2005-11-01
US20080118536A1 (en) 2008-05-22
ATE297408T1 (de) 2005-06-15
KR20020019965A (ko) 2002-03-13
MXPA02001949A (es) 2002-11-07
CN1372567A (zh) 2002-10-02
AU776154B2 (en) 2004-08-26
SK2202002A3 (en) 2002-06-04
JP4942892B2 (ja) 2012-05-30
CZ2002500A3 (cs) 2002-05-15
US8329185B2 (en) 2012-12-11
EP1206488B1 (de) 2005-06-08
RU2242248C2 (ru) 2004-12-20
NO20020884D0 (no) 2002-02-22
DE19939982A1 (de) 2001-03-01
AU6997000A (en) 2001-03-19
CN1205222C (zh) 2005-06-08
PT1206488E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
CA2257133A1 (en) Human dnase i hyperactive variants
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
IL134142A0 (en) Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
HUP0203084A2 (en) Use of baff receptor (bcma) as an immunoregulatory agent
WO2002059604A8 (en) Diagnosis and treatment of multiple sclerosis
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
EP0787988A3 (en) Drug-immobilized particles and a process of purifying proteins
PL353349A1 (pl) Sposób wydzielania i oczyszczania alergenów pyłków traw
EP1597271B1 (de) Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
WO1992000378A1 (de) Dna-sequenz für eine serin-protease und damit zusammenhängende gegenstände
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
NO951750L (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
AU2002224847A1 (en) N-alkylated gaba compounds, processes for their preparation and their use as medicaments
FI950649L (fi) Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet
CA2250433A1 (en) Human dnase ii
SI1351988T1 (sl) IgG-molekule, specifične za alergene skupine 2, in njihova uporaba
DE59607417D1 (de) Konjugat zur behandlung von entzündungserkrankungen
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
EP0826772A3 (de) Humanes Muzin (MUC8)
DE60037195D1 (de) Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung
WO1999006838A3 (en) Novel method of detecting amyloid-like fibrils or protein aggregates
EA199800941A1 (ru) Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона
DE10311106A1 (de) Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung